share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰製藥 | 4：持股變動聲明-董事 SACHS BRUCE I
美股SEC公告 ·  07/17 16:17
Moomoo AI 已提取核心訊息
Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction involving the company's shares on July 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Consequently, the number of shares Sachs held after the transaction remains unknown.
Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction involving the company's shares on July 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Consequently, the number of shares Sachs held after the transaction remains unknown.
Bruce I. Sachs與Vertex Pharmaceuticals Inc. (VRTX)有關，於2024年7月15日進行了一項涉及該公司股票的交易。該公告未披露交易的具體細節，包括股份數量、股票性質、交易價格以及股票總價值。交易類型和交易狀態也沒有提供。因此，Sachs在交易後持有的股票數量仍然未知。
Bruce I. Sachs與Vertex Pharmaceuticals Inc. (VRTX)有關，於2024年7月15日進行了一項涉及該公司股票的交易。該公告未披露交易的具體細節，包括股份數量、股票性質、交易價格以及股票總價值。交易類型和交易狀態也沒有提供。因此，Sachs在交易後持有的股票數量仍然未知。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息